Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.

Mahmud, Ehtisham; Ramsis, Mattheus; Behnamfar, Omid; Enright, Kelly; Huynh, Andrew; Kaushal, Khushboo; Palakodeti, Samhita; Li, Shiqian; Teh, Phildrich; Lin, Felice; Reeves, Ryan; Patel, Mitul; Ang, Lawrence

Mahmud, Ehtisham; Ramsis, Mattheus; Behnamfar, Omid; Enright, Kelly; Huynh, Andrew; Kaushal, Khushboo; Palakodeti, Samhita; Li, Shiqian; Teh, Phildrich; Lin, Felice; Reeves, Ryan; Patel, Mitul; Ang, Lawrence.

Afiliación

Mahmud E; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California. Electronic address: emahmud@ucsd.edu.
Ramsis M; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Behnamfar O; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Enright K; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Huynh A; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Kaushal K; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Palakodeti S; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Li S; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Teh P; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Lin F; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Reeves R; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Patel M; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
Ang L; Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.

Am J Cardiol ; 117(10): 1575-1581, 2016 05 15.

Article en En | MEDLINE | ID: mdl-27040574

Asunto(s)

Síndrome Coronario Agudo/cirugía; Fibrinógeno/metabolismo; Fibrinolíticos/efectos adversos; Infarto del Miocardio/epidemiología; Hemorragia Posoperatoria/epidemiología; Stents; Terapia Trombolítica/efectos adversos; Síndrome Coronario Agudo/sangre; Anciano; California/epidemiología; Femenino; Estudios de Seguimiento; Humanos; Incidencia; Masculino; Infarto del Miocardio/sangre; Infarto del Miocardio/tratamiento farmacológico; Oportunidad Relativa; Intervención Coronaria Percutánea; Hemorragia Posoperatoria/sangre; Pronóstico; Diseño de Prótesis; Estudios Retrospectivos; Tasa de Supervivencia/tendencias; Factores de Tiempo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrinógeno / Stents / Terapia Trombolítica / Hemorragia Posoperatoria / Síndrome Coronario Agudo / Fibrinolíticos / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Am J Cardiol Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google